20n
20n is a Healthcare AI company on Brel, based in United States, founded in 2015. Verified focus: Using AI to predict biochemistry for manufacturing and therapeutics.
AI in Healthcare · United States
Compare
20n vs Aignostics
20n and Aignostics are both classified in the Healthcare sector on Brel. 20n is based in United States; Aignostics is based in Germany. 20n focuses on using AI to predict biochemistry for manufacturing and therapeutics.
What do you want to compare?
Aignostics
Aignostics is a Healthcare AI company on Brel, based in Germany.
AI in Healthcare · Germany
Compare intelligence across Sector Technologies Capabilities Industries served
Key differences
Sector
Same — Healthcare
Country
20n
United States
Aignostics
Germany
Founded
20n
2015
Aignostics
—
Stage
20n
Early
Aignostics
—
Status
20n
Inactive
Aignostics
—
Product summary
20n
Using AI to predict biochemistry for manufacturing and therapeutics
Aignostics
Aignostics Platform
Target customer
20n
—
Aignostics
Pathologists, pharmaceutical partners, and research organizations in digital pathology.
Technologies
20n
—
Aignostics
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Capabilities
20n
Using AI to predict biochemistry for manufacturing and therapeutics
Aignostics
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Industries served
Same — AI in Healthcare
Where they overlap
Sectors
- Healthcare
Industries
- AI in Healthcare
Where they differ
Dimension
20n
Aignostics
Capabilities
Using AI to predict biochemistry for manufacturing and therapeutics
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Technologies
—
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Overview
Attribute
20n
Aignostics
Sector
Healthcare
Healthcare
Country
United States
Germany
Founded
2015
—
Stage
Early
—
Status
Inactive
—
Capabilities
Attribute
20n
Aignostics
Capabilities
Using AI to predict biochemistry for manufacturing and therapeutics
AI pathology and precision medicine analytics platform for research and clinical collaboration, per official materials.
Product summary
Using AI to predict biochemistry for manufacturing and therapeutics
Aignostics Platform
Target customer
—
Pathologists, pharmaceutical partners, and research organizations in digital pathology.
Technology
Attribute
20n
Aignostics
Technologies
—
Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging
Industries & use cases
Attribute
20n
Aignostics
Industries served
AI in Healthcare
AI in Healthcare
Company
Attribute
20n
Aignostics
Linked products
20n
Aignostics AI offering
Trust
Attribute
20n
Aignostics
Verification
verified
verified
Last reviewed
Aug 2026
Aug 2026
Sources & verification
20n
- Verification
- verified
- Last reviewed
- Aug 2026
- Profile
- Open profile
Aignostics
- Verification
- verified
- Last reviewed
- Aug 2026
- Profile
- Open profile